1.
Emerg Infect Dis
; 30(5): 1050-1052, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38666742
RESUMO
Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain-specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.